Position in UPB
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$3,420,549
-$33,002,262 QoQ
Shares Held
380,061
-71.7% QoQ
Ownership
0.698%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UPB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Altshuler Shaham Ltd holds $5,376,930 across 16 Biotechnology names. UPB ranks #1 (63.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UPB |
Upstream Bio, Inc.
This page
|
380,061 | $3,420,549 | |
| 2 | VYGR |
Voyager Therapeutics, Inc.
|
273,925 | $1,057,350 | |
| 3 | MRNA |
Moderna, Inc.
|
15,100 | $767,080 | |
| 4 | ORMP |
Oramed Pharmaceuticals Inc.
|
11,211 | $38,117 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
500 | $23,785 | |
| 6 | PLX |
Protalix BioTherapeutics, Inc.
|
7,742 | $16,800 | |
| 7 | DRTS |
Alpha Tau Medical Ltd.
|
2,300 | $16,261 | |
| 8 | CGEN |
Compugen Ltd
|
4,000 | $8,520 |
All Filings in UPB
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,420,549 | 380,061 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $36,422,811 | 1,341,540 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $26,650,421 | 1,416,822 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $37,270,961 | 3,394,441 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $19,799,993 | 3,235,293 | Shares | Defined | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||